Sequence 50 from Patent EP1749840. Sequence 50 from patent US 5783184. Sequence 50 from patent US 5851525. Sequence 50 from patent US 6129913. Sequence 50 from patent US 6946130. Sequence 50 from patent US 5683892. Sequence 50 from patent US 5693323. Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders. IMPROVED METHOD FOR TREATMENT AND DIAGNOSIS OF IL-5 MEDIATED DISORDERS. Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders. Sequence 50 from patent US 7399837. Sequence 50 from patent US 7982005. JP 2000515494-A/34: Improved method for treating and diagnosing IL-5-mediated disorder.